Treatment of cornual viable pregnancy with single dose methotrexate: Case report
Neval Yaman Görük 1 * , Ahmet Göçmen, Mustafa Gazi Uçar, Senem Yaman Tunç, Özlem Tosun
More Detail
1 Ümraniye Eğitim ve Araştırma Hastanesi, Kadın Doğum Kliniği, İstanbul, Turkey* Corresponding Author


We herein report a case of cornual viable pregnancy that was successfully treated with a single dose methotrexate without the need for surgical intervention. A 37 year-old woman was diagnosed cornual pregnancy based on transvaginal ultrasound findings and hormonal assays. A single dose systemic methotrexate (50 mg/m2) was administered. No side effects were experienced. Early diagnosis of interstitial pregnancy can lead to conservative treatment options. Although the most effective methotrexate protocol for conservative treatment is uncertain we concluded that in the hemodynamically stable patient a single dose systemic methotrexate treatment is a useful and should be considered as the first line treatment. This is safe and highly effective management even though viable fetus or high level of human chorionic gonadotropin (B-hCG) was assigned. Hemodynamic stability is the most important criteria and that is directly correlated with the early diagnosis. Surgery can be avoided; however, with conservative management a longer and close follow-up is required.


This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Case Report

J Clin Exp Invest, 2012, Volume 3, Issue 1, 105-107

Publication date: 13 Mar 2012

Article Views: 2733

Article Downloads: 1277

Open Access References How to cite this article